Search Results 641-650 of 18088 for multiple%20sclerosis
A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis · Overview · Participation eligibility.
... multiple sclerosis. Knowing which diseases occur more often in males or females and at what age is critical in understanding the pathogenesis of disease and ...
Functional neurologic disorder is related to how the brain functions, rather than damage to the brain's structure (such as from a stroke, multiple sclerosis, ...
Primary lateral sclerosis, Guillain Barre syndrome ... Cognitive behavioral therapy, Polysomnography, Actigraphy, Multiple sleep latency test, PAP therapy, ...
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
Exploring the link between the gut and multiple sclerosis. Mayo Clinic Staff. February 21, 2017. Research. New ray of light for those who struggle with weight ...
The objectives of this study are to determine the impact of type, dose, and duration of exogenous glucocorticoid therapy on development of adrenal insufficiency ...
Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey. J Neurol Sci. 2023 Oct 15; 453 ...
* The participant has a diagnosis of clinically established multiple system atrophy parkinsonian type (MSA-P) or multiple system atrophy cerebellar type ...
Twenty-one years ago, when Diane Kolmer began her battle with multiple sclerosis (MS), she came to Mayo Clinic looking for answers about the progression of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.